 |
|
|
| |
Sequential ART Interruptions Boost Autologous Neutralizing Antibodies (aNAbs) and Constrain Rebound Variants
|
| |
| |
CROI 2026 Feb 22-25 Denver
Karl Stefic1,2, Behzad Etemad1, Nickolaus Jilg1, Madison Mabardy1, Sang Hyeon Kim1, Efthimios Deligiannidis1, Flavio Mesquita1, Christy L. Lavine3, Joseph J. Eron4, Ian Frank5, Jeffrey M. Jacobson6, Michael S. Seaman3, Jonathan Z. Li1
1Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, USA, 2Université de Tours, INSERM U1259 MAVIVHe, Tours, France, 3Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA, 4University of North Carolina, Chapel Hill, NC, USA, 5University of Pennsylvania, Philadelphia, PA, USA, 6Case Western Reserve University, Cleveland, OH, USA
from Jules: in my opinion the safety of these ATIs have never & has yet to be adequately studied or established, regarding long term impact on cognitive function, comorbidities, etc.
|
| |
|
|
|
|
|
